GlassScriptPhysician profile
Matthew Thomas Bell
NPI 1295316263
$1,399.55
in general payments reported to CMS, 2019-2025
12 companies · $1,190 in 2025
The $1,190 reported for 2025 was more than what 87% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $120 · 2024: $89.42 · 2025: $1,190.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,400.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,399.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| 3-D Matrix, INC. | $763.86 | 2025 | |
| Abbvie INC. | $217.40 | 2025 | |
| Janssen Biotech, INC. | $112.40 | 2024-2025 | Tremfya |
| Olympus America INC. | $87.02 | 2025 | Single Use Aspiration Needle Na-U200h, Endoclot Phs, Single Use Electrosurgical Knife Kd-655 |
| Emd Serono, INC. | $61.53 | 2023 | Bavencio |
| Genmab U.S., INC. | $34.44 | 2023 | Epkinly |
| Phathom Pharmaceuticals, INC. | $25.71 | 2024 | Voquezna |
| Mirati Therapeutics, INC. | $23.77 | 2023 | Krazati |
| Ardelyx, INC. | $20.72 | 2025 | Ibsrela |
| Bayer Healthcare Pharmaceuticals INC. | $19.02 | 2024 | |
| Conmed Corporation | $17.53 | 2025 | Conmed Biliary |
| Ipsen Biopharmaceuticals, INC | $16.15 | 2025 | Iqirvo |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Bell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.